AI filing briefs · archive

8-K filings in August 2026, explained

2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

4 of 2,914 briefs match

newest first · times in ET
FNFabrinet Aug 17, 4:22 PM ET

Fabrinet posts record Q4 revenue of $1.32 billion and guides first quarter higher

Positive earnings Written later 1.012.022.035.02

Fabrinet reported record fourth-quarter fiscal 2026 revenue of $1,315.8 million, up from $909.7 million a year earlier, and GAAP diluted EPS of $3.83 versus $2.42. The company guided first-quarter fiscal 2027 revenue to $1.375 billion to $1.425 billion and non-GAAP diluted EPS to $4.10 to $4.25, and its Thai subsidiary took a term loan of about $75.0 million guaranteed by Fabrinet.

  • Q4 fiscal 2026 revenue of $1,315.8 million, up from $909.7 million; GAAP net income of $139.3 million versus $87.2 million
  • Fiscal 2027 first-quarter guidance: revenue of $1.375 billion to $1.425 billion; non-GAAP EPS of $4.10 to $4.25
  • On August 17, 2026, Fabrinet Co., Ltd. borrowed a THB 2.50 billion (about $75.0 million) term loan from Bank of Ayudhya, guaranteed by Fabrinet, to support capital expenditures
  • On August 11, 2026, the compensation committee raised CEO Seamus Grady's base salary to $1,500,000 and set his fiscal 2027 target bonus at $2,625,000
Read the filing on SEC.gov ↗
EPEMPIRE PETROLEUM CORP Aug 17, 4:08 PM ET

Empire Petroleum Q2 revenue rises 27% to $11.1 million; net loss narrows

Positive earnings Written later 2.02

Empire Petroleum reported second-quarter 2026 product revenue of $11.1 million, up from $8.7 million a year earlier, and a net loss of $1.9 million, or $0.05 per diluted share, compared with a $5.1 million loss, or $0.15 per share, in Q2 2025. The filing attributes the higher revenue mainly to higher realized oil pricing, partly offset by lower production, and the company gave qualitative operating updates without a numeric forecast.

  • Total product revenue was $11.1 million in Q2 2026, up from $8.7 million in Q2 2025 and $7.7 million in Q1 2026.
  • Net loss was $1.9 million, or $0.05 per diluted share, versus a $5.1 million loss, or $0.15 per share, in Q2 2025.
  • Adjusted EBITDA was $0.4 million, compared with negative $1.2 million in Q2 2025.
  • Cash on hand was $3.1 million at June 30, 2026; no shares had been sold under a $7.5 million at-the-market sales agreement with Roth Capital Partners.
Read the filing on SEC.gov ↗
LEXXLexaria Bioscience Corp. Aug 17, 12:37 PM ET

Lexaria Bioscience regains Nasdaq bid price compliance, hearing cancelled

Positive legal/regulatory Written later 8.01

Lexaria Bioscience Corp. received a letter from Nasdaq on August 17, 2026 confirming that it has regained compliance with the minimum bid price requirement in Nasdaq Listing Rule 5550(a)(2). As a result, the previously requested hearing was cancelled and the company's common stock will continue to be listed and trade on The Nasdaq Capital Market, which removes the near-term risk of delisting for shareholders.

  • Nasdaq letter dated August 17, 2026 confirmed compliance with the bid price requirement in Listing Rule 5550(a)(2)
  • Previously requested hearing has been cancelled
  • Common stock will continue to be listed and trading on The Nasdaq Capital Market
Read the filing on SEC.gov ↗
CSAICLOUDASTRUCTURE, INC. Aug 17, 7:13 AM ET

Cloudastructure regains Nasdaq bid price compliance; Q2 revenue up 13%

Positive earnings Written later 2.023.01

Cloudastructure reported second-quarter 2026 revenue of $1.2 million, up about 13% from a year earlier, with gross profit up 53% and the net loss narrowing to about $1.7 million. The company also said Nasdaq has confirmed it regained compliance with the $1.00 minimum bid price rule, closing a matter that had threatened its Nasdaq Capital Market listing.

  • Q2 2026 revenue was $1.2 million versus $1.1 million; subscription revenue rose 164% to $764,000
  • Net loss narrowed to about $1.7 million from about $2.2 million, helped by a non-cash $319,000 derivative gain
  • Nasdaq letter dated August 14, 2026 confirmed a closing bid of $1.00 or more from July 31 through August 13, 2026
  • Cash on hand was about $3.8 million as of June 30, 2026
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.